Seattle Genetics exercises option to codevelop second antibody-drug conjugate with Agensys June 10, 2011
Halozyme and Intrexon sign licensing agreement to develop subcutaneous rHuA1AT formulation June 9, 2011
Merck & Co. and Roche to apply Roche's diagnostic assays to Merck & Co.'s anticancer portfolio June 9, 2011
Dainippon Sumitomo Pharma and University of Tokyo expand collaboration for CD5 antigen-like June 9, 2011
RSS